Washington Post: Obese Americans suffer disproportionately from the coronavirus
UC expert says the dysregulated immune response in obese people could impact vaccine efficacy
While the obesity epidemic has made it harder for the United States to fight the COVID-19 pandemic, at the same time, the pandemic has made it harder for Americans to fight obesity.
In an article examining this issue, the Washington Post turned to several experts, including Rajat Madan, MD, of the Division of Infectious Diseases at the UC College of Medicine.
Madan pointed out results from the Pfizer vaccine trial found similar results in vaccine efficacy between obese and non-obese populations. But he told the Post it might be possible obese people will see their immunity wane faster or will need an extra booster shot.
“Obese individuals have a dysregulated immune response. In that sense, one would think that COVID-19 vaccines may have less efficacy,” Madan said.
The Washington Post report says researchers have found having obesity already increases one’s likelihood of hospitalization for COVID-19 by 113% and chances of dying of the illness by 48%.
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
Local 12: Head injury survivor, doctor share importance of...
April 23, 2024
Local 12 spoke with patient Shane Shapiro and the University of Cincinnati's Laura Ngwenya about the importance of wearing a helmet following Shapiro's traumatic brain injury and recovery.
WVXU: Why is part of Green Township called Dent?
April 23, 2024
UC College of Arts and Sciences professor tells WVXU that Ohio's glacial past might explain how Dent got its name.
WVXU: Find your CPAP annoying? UC researchers are working on a...
April 22, 2024
Dr. Liran Oren is leading a research team at the University of Cincinnati developing a VortexPAP machine that takes advantage of vortex airflow technology. A preliminary clinical study with current CPAP users demonstrated that the VortexPAP can deliver the pressure levels that are used in the subjects’ CPAP therapy, but the mask is more comfortable to wear. It has a minimalistic design that is less intrusive and barely touches the patient’s face.